These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 10865926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Vaginal candidiasis--treatment protocols using miconazole and fluconazole].
    Mazneĭkova V.
    Akush Ginekol (Sofiia); 2003; 42 Suppl 2():30-4. PubMed ID: 14619753
    [Abstract] [Full Text] [Related]

  • 6. Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy.
    Ventolini G, Baggish MS, Walsh PM.
    J Reprod Med; 2006 Jun; 51(6):475-8. PubMed ID: 16846086
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis)].
    Borisov I, Kolarov G, Bobcheva S, Ivanova A.
    Akush Ginekol (Sofiia); 2005 Jun; 44 Suppl 2():17-20. PubMed ID: 16028398
    [Abstract] [Full Text] [Related]

  • 8. Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole.
    Sobel JD, Schmitt C, Stein G, Mummaw N, Christensen S, Meriwether C.
    J Reprod Med; 1994 Jul; 39(7):517-20. PubMed ID: 7966041
    [Abstract] [Full Text] [Related]

  • 9. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W, Brasch J, Cornely OA, Effendy I, Friese K, Ginter-Hanselmayer G, Hof H, Mayser P, Mylonas I, Ruhnke M, Schaller M, Weissenbacher ER.
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [Abstract] [Full Text] [Related]

  • 10. Managing patients with vulvovaginal candidiasis.
    Elliott KA.
    Nurse Pract; 1998 Mar; 23(3):44-6,49-53. PubMed ID: 9560829
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
    Pekhlivanov B, Amaliev I, Ivancheva Kh, Zisova L.
    Akush Ginekol (Sofiia); 2005 Mar; 44 Suppl 2():25-7. PubMed ID: 16028400
    [Abstract] [Full Text] [Related]

  • 12. Post-menopausal recurrent vaginal candidiasis: effect of hysterectomy on response to treatment, type of colonization and recurrence rates post-treatment.
    Ventolini G, Baggish MS.
    Maturitas; 2005 Jul 16; 51(3):294-8. PubMed ID: 15978973
    [Abstract] [Full Text] [Related]

  • 13. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W, Brasch J, German Society for Gynecology and Obstetrics, Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, German Society of Dermatology, the Board of German Dermatologists, German Speaking Mycological Society.
    Mycoses; 2012 Jul 16; 55 Suppl 3():1-13. PubMed ID: 22519657
    [Abstract] [Full Text] [Related]

  • 14. Chronic vulvovaginal candidosis: the role of oral treatment.
    Merkus JM, Van Heusden AM.
    Br J Clin Pract Suppl; 1990 Sep 16; 71():81-4. PubMed ID: 1965421
    [Abstract] [Full Text] [Related]

  • 15. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D, Goswami R, Dadhwal V, Goswami D, Banerjee U, Kochupillai N.
    J Infect; 2007 Oct 16; 55(4):374-7. PubMed ID: 17692922
    [Abstract] [Full Text] [Related]

  • 16. [Vulvovaginal candidiasis: a therapeutic approach].
    Battaglia F, Mariani L, Anglana F, Milite V, Quattrini M, Plotti F, Tomao F, Plotti G.
    Minerva Ginecol; 2005 Apr 16; 57(2):131-9. PubMed ID: 15940073
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study.
    Patel DA, Gillespie B, Sobel JD, Leaman D, Nyirjesy P, Weitz MV, Foxman B.
    Am J Obstet Gynecol; 2004 Mar 16; 190(3):644-53. PubMed ID: 15041994
    [Abstract] [Full Text] [Related]

  • 18. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis.
    Sobel JD.
    Obstet Gynecol; 1985 Mar 16; 65(3):435-40. PubMed ID: 3838374
    [Abstract] [Full Text] [Related]

  • 19. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
    Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME.
    J Womens Health (Larchmt); 2011 Aug 16; 20(8):1245-55. PubMed ID: 21774671
    [Abstract] [Full Text] [Related]

  • 20. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
    Kjaeldgaard A.
    Pharmatherapeutica; 1986 Aug 16; 4(8):525-31. PubMed ID: 3520601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.